1. Home
  2. SSM vs NRSN Comparison

SSM vs NRSN Comparison

Compare SSM & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono Group N.V. Ordinary Shares

SSM

Sono Group N.V. Ordinary Shares

BUY

Current Price

$1.13

Market Cap

6.4M

Sector

N/A

ML Signal

BUY

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

BUY

Current Price

$2.41

Market Cap

7.6M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
SSM
NRSN
Founded
2016
2017
Country
Germany
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
7.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SSM
NRSN
Price
$1.13
$2.41
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $78.50
AVG Volume (30 Days)
★ 2.2M
17.8K
Earning Date
11-19-2026
09-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$1,447,140.40
N/A
Revenue Next Year
$48.46
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$0.25
52 Week High
$10.54
$7.50

Technical Indicators

Market Signals
Indicator
SSM
NRSN
Relative Strength Index (RSI) 39.91 37.25
Support Level $1.05 $0.63
Resistance Level $2.58 $7.50
Average True Range (ATR) 0.12 0.37
MACD 0.04 -0.24
Stochastic Oscillator 7.95 14.04

Price Performance

Historical Comparison
SSM
NRSN

About SSM Sono Group N.V. Ordinary Shares

Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and services include Complete Solar Solutions, Solar Charge Controllers, Solar Modules, Data Services, and Engineering Services. The company's single business segment manages the financing, research and development, and product commercialization.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: